Literature DB >> 2917188

Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children.

S M Hanash1, R Kuick, J Strahler, B Richardson, G Reaman, L Stoolman, C Hanson, D Nichols, H J Tueche.   

Abstract

We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917188

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

2.  High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia.

Authors:  Gero Hütter; Anne Letsch; Daniel Nowak; Julia Poland; Pranav Sinha; Eckhard Thiel; Wolf-K Hofmann
Journal:  J Transl Med       Date:  2009-01-15       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.